Wataru Akahata

2.1k citations

26 papers · 1.4k indexed · h-index 16

Infectious Diseases top 1%
- Viral Infections and Vectors 9
- Viral Infections and Outbreaks Research 4
- SARS-CoV-2 and COVID-19 Research 2
Virology top 5%
- HIV Research and Treatment 10
Public Health, Environmental and Occupational Health top 2%
- Mosquito-borne diseases and control 11
Immunology
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 3
Epidemiology top 10%
Ecology
- Bacteriophages and microbial interactions 2

Co-authors: Gary J. Nabel Michael G. Rossmann Siyang Sun Heather A. Holdaway Mark G. Lewis Srinivas S. Rao Zhiyong Yang Michael Diamond
Cited by: Infectious Diseases Virology Public Health, Environmental and Occupational Health
Journals: Proceedings of the National Academy of Sciences (2 papers)The Lancet (1 paper)Nature Medicine (1 paper)
Partner nations: United States Japan United Kingdom

In The Last Decade

Wataru Akahata

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by Wataru Akahata

Since Specialization

Citations

This map shows the geographic impact of Wataru Akahata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Akahata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Akahata more than expected).

Fields of papers citing papers by Wataru Akahata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Akahata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Akahata. The network helps show where Wataru Akahata may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wataru Akahata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wataru Akahata Line = papers co-authored together Wataru Akahata links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Incorporation of 5-methylcytidine alleviates RIG-I–mediated innate immune responses to a self-amplifying RNA vaccine Science Translational Medicine ·Wataru Akahata,Mai Komori,Amber L. Morey,Andrés A. Quiñones-Molina,James B. Hood,Josiane Fofana,Luis Romero,Elizabeth Peters,J. J. Webber,Tyler Meeks,Paulina A. Przygonska,Isabel Steinberg,Ellison Ober,Tae Min Kim,Daniel C. Rogan,Kenta Matsuda,Jonathan F. Smith,Suryaram Gummuluru,Mark Connors,Hisashi Akiyama	2025	0
2	Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery Journal of Controlled Release ·Madison M. Driskill,Ian A. Coates,Paul J. Hurst,Netra U. Rajesh,Maria T. Dulay,Robert M. Waymouth,Wataru Akahata,Kenta Matsuda,Jonathan Smith,Gunilla B. Jacobson,Jillian L. Perry,Shaomin Tian,Joseph M. DeSimone	2025	2
3	Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine iScience ·Masayuki Aboshi,Kenta Matsuda,Daisuke Kawakami,Kaoru Kono,Yoko Kazami,Takashi Sekida,Mai Komori,Amber L. Morey,Shigeru Suga,Jonathan Smith,Takasuke Fukuhara,Yasumasa Iwatani,Takuya Yamamoto,Nobuaki Sato,Wataru Akahata	2024	19
4	A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates Journal of Virology ·Daniel Thoresen,Kenta Matsuda,Akane Urakami,Mya Myat Ngwe Tun,Takushi Nomura,Meng Ling Moi,Yuri Watanabe,Momoko Ishikawa,Trang Thi Thu Hau,Hiroyuki Yamamoto,Yuriko Suzaki,Yasushi Ami,Jonathan Smith,Tetsuro Matano,Kouichi Morita,Wataru Akahata	2024	14
5	saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern Nature Communications ·Mai Komori,Takuto Nogimori,Amber L. Morey,Takashi Sekida,Keiko Ishimoto,Matthew R. Hassett,Yuji Masuta,Hirotaka Ode,Tomokazu Tamura,Rigel Suzuki,Jeff Alexander,Yasutoshi Kido,Kenta Matsuda,Takasuke Fukuhara,Yasumasa Iwatani,Takuya Yamamoto,Jonathan Smith,Wataru Akahata	2023	17
6	Reassessing therapeutic antibodies for neglected and tropical diseases PLoS neglected tropical diseases ·Rob Hooft van Huijsduijnen,Somei Kojima,Dee Carter,Hisafumi Okabe,Akihide Sato,Wataru Akahata,Timothy N. C. Wells,Kei Katsuno	2020	20
7	An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design Journal of Virology ·Akane Urakami,Mya Myat Ngwe Tun,Meng Ling Moi,Atsuko Sakurai,Momoko Ishikawa,S Kuno,Ryuji Ueno,Kouichi Morita,Wataru Akahata	2017	48
8	Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission Journal of Virology ·Jason Porta,Vidya Mangala Prasad,Cheng‐I Wang,Wataru Akahata,Lisa F. P. Ng,Michael G. Rossmann	2015	22
9	Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity Proceedings of the National Academy of Sciences ·Feng Long,Rachel H. Fong,S. Kyle Austin,Zhenguo Chen,Thomas Klose,Andrei Fokine,Yue Liu,Jason Porta,Gopal Sapparapu,Wataru Akahata,Benjamin J. Doranz,James E. Crowe,Michael Diamond,Michael G. Rossmann	2015	47
10	Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial The Lancet ·Lee-Jah Chang,Kimberly A. Dowd,Floreliz Mendoza,Jamie Saunders,Sandra Sitar,Sarah H. Plummer,Galina V. Yamshchikov,Uzma Sarwar,Zonghui Hu,Mary E. Enama,Robert T. Bailer,Richard A. Koup,Richard Schwartz,Wataru Akahata,Gary J. Nabel,John R. Mascola,Theodore C. Pierson,Barney S. Graham,Julie E. Ledgerwood	2014	182
11	Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus PLoS Pathogens ·Pankaj Pal,Kimberly A. Dowd,James D. Brien,Melissa A. Edeling,Sergey Gorlatov,Syd Johnson,Iris Lee,Wataru Akahata,Gary J. Nabel,Mareike K. S. Richter,Jolanda M. Smit,Daved H. Fremont,Theodore C. Pierson,Mark T. Heise,Michael Diamond	2013	245
12	A Specific Domain of the Chikungunya Virus E2 Protein Regulates Particle Formation in Human Cells: Implications for Alphavirus Vaccine Design Journal of Virology ·Wataru Akahata,Gary J. Nabel	2012	42
13	A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection Nature Medicine ·Wataru Akahata,Zhiyong Yang,Hanné Andersen,Siyang Sun,Heather A. Holdaway,Wing‐Pui Kong,Mark G. Lewis,Stephen Higgs,Michael G. Rossmann,Srinivas S. Rao,Gary J. Nabel	2010	367
14	Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity The Journal of Immunology ·Mitsuo Honda,Rui Wang,Wing-Pui Kong,Masaru Kanekiyo,Wataru Akahata,Ling Xu,Kazuhiro Matsuo,Kannan Natarajan,Howard Robinson,Tedi E. Asher,David A. Price,Daniel C. Douek,David H. Margulies,Gary J. Nabel	2009	18
15	Protein Methyltransferase 2 Inhibits NF-κB Function and Promotes Apoptosis Molecular and Cellular Biology ·Ganesh Lakshmanan,Takanobu Yoshimoto,Narayani Chandra Moorthy,Wataru Akahata,Manfred Boehm,Elizabeth G. Nabel,Gary J. Nabel	2006	86
16	Analysis of evolutionary conservation in CD1d molecules among primates Tissue Antigens ·Naoki Saito,Megumi Takahashi,Wataru Akahata,Eiji Ido,Chizuno Hidaka,Kazuyasu Ibuki,Tsuyoshi Miura,Masanori Hayami,Hidemi Takahashi	2005	4
17	DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles Vaccine ·R. Horiuchi,Wataru Akahata,Takeo Kuwata,Yoshimi Enose,Eiji Ido,Hajime Suzuki,Ariko Miyake,Naoki Saito,Kentaro Ibuki,Toshiyuki Goto,Tomoyuki Miura,Masanori Hayami	2005	5
18	Comparative Immunogenicity of Human Immunodeficiency Virus Particles and Corresponding Polypeptides in a DNA Vaccine Journal of Virology ·Wataru Akahata,Zhi-Yong Yang,Gary J. Nabel	2004	7
19	DNA Vaccination of Macaques by a Full Genome HIV-1 Plasmid Which Produces Noninfectious Virus Particles Virology ·Wataru Akahata,Eiji Ido,Toshihide Shimada,Kazuki Katsuyama,Hiroshi Yamamoto,Hiromi Uesaka,Masahiro Ui,Takeo Kuwata,Hidemi Takahashi,Masanori Hayami	2000	20
20	Sequential Analysis of Apoptosis Induction in Peripheral Blood Mononuclear Cells and Lymph Nodes in the Early Phase of Pathogenic and Nonpathogenic SIVmac Infection AIDS Research and Human Retroviruses ·Tohko Iida,Hiroshi Ichimura,Masahiro Ui,Toshihide Shimada,Wataru Akahata,Tatsuhiko Igarashi,Takeo Kuwata,Eiji Ido,Shin Yonehara,Jirô Imanishi,Masanori Hayami	1999	15

About Wataru Akahata

Wataru Akahata is a scholar working on Virology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (11 papers), HIV Research and Treatment (10 papers), Viral Infections and Vectors (9 papers), Immunotherapy and Immune Responses (6 papers), Viral Infections and Outbreaks Research (4 papers), Immune Cell Function and Interaction (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Infectious Diseases (958 citations), Virology (218 citations) and Public Health, Environmental and Occupational Health (931 citations). Wataru Akahata has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Gary J. Nabel, Michael G. Rossmann, Siyang Sun, Heather A. Holdaway, Mark G. Lewis, Srinivas S. Rao, Zhiyong Yang, Michael Diamond, Stephen Higgs and Hanné Andersen. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact